Item Type |
Article |
ID |
|
Preview |
Image |
|
Caption |
|
|
Full text |
KAKEN_23591517seika.pdf
Type |
:application/pdf |
Download
|
Size |
:172.6 KB
|
Last updated |
:Dec 11, 2014 |
Downloads |
: 4575 |
Total downloads since Dec 11, 2014 : 4575
|
|
Release Date |
|
Title |
Title |
DUOX2遺伝子変異による先天性甲状腺機能低下症の有病率・臨床像・分子機序の解明
|
Kana |
DUOX2 イデンシ ヘンイ ニ ヨル センテンセイ コウジョウセン キノウ テイカショウ ノ ユウビョウリツ・リンショウゾウ・ブンシ キジョ ノ カイメイ
|
Romanization |
DUOX2 idenshi heni ni yoru sentensei kojosen kino teikasho no yubyoritsu rinshozo bunshi kijo no kaimei
|
|
Other Title |
Title |
Prevalence, clinical manifestation, and molecular mechanism of congenital hypothyroidism due to DUOX2 abnormality
|
Kana |
|
Romanization |
|
|
Creator |
Name |
長谷川, 奉延
|
Kana |
ハセガワ, トモノブ
|
Romanization |
Hasegawa, Tomonobu
|
Affiliation |
慶應義塾大学・医学部・教授
|
Affiliation (Translated) |
|
Role |
Research team head
|
Link |
科研費研究者番号 : 20189533
|
Name |
鳴海, 覚志
|
Kana |
ナルミ, サトシ
|
Romanization |
Narumi, Satoshi
|
Affiliation |
慶應義塾大学・医学部・特任助教
|
Affiliation (Translated) |
|
Role |
Research team member
|
Link |
科研費研究者番号 : 40365317
|
|
Edition |
|
Place |
|
Publisher |
|
Date |
Issued (from:yyyy) |
2014
|
Issued (to:yyyy) |
|
Created (yyyy-mm-dd) |
|
Updated (yyyy-mm-dd) |
|
Captured (yyyy-mm-dd) |
|
|
Physical description |
|
Source Title |
Name |
科学研究費補助金研究成果報告書
|
Name (Translated) |
|
Volume |
|
Issue |
|
Year |
2013
|
Month |
|
Start page |
|
End page |
|
|
ISSN |
|
ISBN |
|
DOI |
|
URI |
|
JaLCDOI |
|
NII Article ID |
|
Ichushi ID |
|
Other ID |
|
Doctoral dissertation |
Dissertation Number |
|
Date of granted |
|
Degree name |
|
Degree grantor |
|
|
Abstract |
両アリル性DUOX2変異(DUOX2異常症)による永続性先天性甲状腺機能低下症(CH)は常染色体劣性遺伝病であり、その有病率は一般人口の1/44,000、CH の8/102(7.8%)である。DUOX2異常症による永続性CHの臨床症状は新生児期に重症でその後軽症化する。DUOX2異常症は一過性CH、遅発性CHを示すこともある。片アレル性DUOX2変異保有者は多因子遺伝病として1%未満にCHを発症するにすぎない。片アレル性DUOX2変異かつ片アレル性TSHR変異の二重保因者のCH発症リスクは3.7%である。
変異DUOX2分子の発現実験系での機能解析方法を確立した。
The prevalence of congenital hypothyroidism (CH) due to biallelic DUOX2 mutations is 1/44,000 in Japan. In CH, the prevalence of biallelic DUOX2 mutations is 8/102 (7.8%). The inheritance mode of biallelic DUOX2 mutations is autosomal recessive. CH due to biallelic DUOX2 mutations has some characteristics as follows: It is permanent, transient, or late-onset. Clinical findings in neonatal period are severe, while they improve by the age of 2 years. Environmental factors such as maternal iodine exposure can affect clinical findings. Biochemical study does not always show defects of iodine organization. In contrast, monoallelic DUOX2 mutation rarely (<1%) develops CH. The inheritance mode of CH related to monoallelic DUOX2 mutation is multifactorial. 3.7 % of subjects having both monoallelic DUOX2 mutation and monoallelic TSHR mutation develop CH.
I have established in vitro assay to characterize function of wild or mutant DUOX2 molecule.
|
|
Table of contents |
|
Keyword |
|
NDC |
|
Note |
研究種目 : 基盤研究(C)
研究期間 : 2011~2013
課題番号 : 23591517
研究分野 : 医歯薬学
科研費の分科・細目 : 内科系臨床医学・小児科学
|
|
Language |
|
Type of resource |
|
Genre |
|
Text version |
|
Related DOI |
|
Access conditions |
|
Last modified date |
|
Creation date |
|
Registerd by |
|
History |
|
Index |
|
Related to |
|